Spectrofluorometric determination of certain quinolone antibacterials using metal chelation

被引:93
作者
El-Kommos, ME [1 ]
Saleh, GA [1 ]
El-Gizawi, SM [1 ]
Abou-Elwafa, A [1 ]
机构
[1] Univ Assiut, Fac Pharm, Dept Pharmaceut Analyt Chem, Assiut 71526, Egypt
关键词
quinolones; metal chelates; spectrofluorometry; assosiation constants;
D O I
10.1016/S0039-9140(03)00171-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Simple, rapid, reliable, and sensitive spectrofluorometric methods were developed for the determination of eight quinolone antibacterials namely ciprofloxacin, norfloxacin, lomefloxacin, difloxacin, amifloxacin, pefloxacin, ofloxacin, and nalidixic acid. The methods depend on the chelation of each of the studied drugs with zirconium, molybdenum, vanadium or tungsten to produce fluorescent chelates. Different factors affecting the relative fluorescence intensity of the resulting chelates were studied and optimised. At the optimum reaction conditions, the drug-metal chelates showed excitation maxima ranging from 274 to 295 nm and emission maxima ranging from 409 to 495 nm. The chelates were found to be stable at room temperature for 2 days and show good stability upon increasing temperature to 50 degreesC for about 1 h. Rectilinear calibration graphs were obtained in the range of 10-60 ng ml(-1) for each of the investigated drugs and the limits of detection and quantitation ranged from 1.214 to 2.046 and from 4.047 to 6.819 ng ml(-1), respectively. The molar ratios of the formed chelates were determined by Job's method and their association constants were also calculated. The developed methods were applied successfully for the determination of the studied drugs in their pharmaceutical dosage forms with a good precision and accuracy compared to official and reported methods as revealed by t- and F-tests. They were also applied for the determination of studied drugs in spiked urine and plasma samples. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1033 / 1050
页数:18
相关论文
共 37 条
[1]   Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography [J].
Abanmi, N ;
Zaghloul, I ;
ElSayed, N ;
AlKhamis, KI .
THERAPEUTIC DRUG MONITORING, 1996, 18 (02) :158-163
[2]   CHEMICAL AND MICROBIOLOGICAL INVESTIGATIONS OF METAL-ION INTERACTION WITH NORFLOXACIN [J].
ALKAYSI, HN ;
ABDELHAY, MH ;
SALEM, MS ;
GHARAIBEH, AM ;
NAWAS, TE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :73-77
[3]  
*AM PHARM ASS, 2000, US STAT PHARM 24 NF
[4]  
[Anonymous], 1998, British Pharmacopoeia
[5]  
ARTESROS AH, 1998, ANALYST, V123, P609
[6]  
BARAZA A M C, 1985, Revista de Farmacia e Bioquimica da Universidade de Sao Paulo, V21, P141
[7]   Determination of norfloxacin by fluorescence in the presence of different antacids: Quantification of analytical interferences [J].
CordobaBorrego, M ;
CordobaDiaz, M ;
Bernabe, I ;
CordobaDiaz, D .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (8-10) :977-982
[8]   Stability-indicating methods for the spectrophotometric determination of norfloxacin [J].
El Khateeb, SZ ;
Razek, SAA ;
Amer, MM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (4-5) :829-840
[9]   Determination of norfloxacin spectrophotometrically using 2,4-dinitrofluorobenzene [J].
El Walily, AFM ;
Razak, OA ;
Belal, SF ;
Bakry, RS .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (05) :1069-1076
[10]   SPECTROPHOTOMETRIC AND SPECTROFLUOROMETRIC DETERMINATION OF OFLOXACIN [J].
ELYAZBI, FA .
SPECTROSCOPY LETTERS, 1992, 25 (02) :279-291